A股異動 | 納思達(002180.SZ)漲4.5% 一季度淨利預增超494%
格隆匯3月17日丨納思達(002180.SZ)今日跳空高開,現漲4.47%,報26.85元,成交額擴大至近2億元,總市值289億元。納思達16日公吿,預計第一季度淨利潤為1.8億-2.7億元,同比增長493.91%-790.87%。2021年第一季度與去年同期相比,全球新冠疫苗接種在持續加快,新冠疫情明顯緩解,全球打印機市場表現出增長趨勢,打印機耗材需求也隨之釋放,公司打印機通用耗材業務、艾派克微電子業務模塊的銷量和收入均呈現出不同程度增長趨勢。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.